is an effective lipid-lowering treatment in hypercholester olemic patients who have coronary artery disease and are refractory to drugs. More aggressive lipid-lowering ther apy may further slow the progression of atherosclerosis. Objective: To compare the effect of LDL apheresis and simvastatin therapy with the effect of simvastatin therapy alone on the progression of peripheral vascular disease. Conclusions: Aggressive lipid lowering with simvastatin and LDL apheresis decreased the intima-media thickness of the carotid artery and prevented an increase in the number of hemodynamically significant stenoses in the lower limbs. Therapy with simvastatin alone did not pre vent progression of carotid or aortotibial vascular disease
Item does not contain fulltextBACKGROUND: High LDL-cholesterol is a risk factor for atherosclerosis....
ObjectivesIn a randomized study we evaluated the effect of biweekly low density lipoprotein (LDL) ap...
Statins lower low density lipoprotein-cholesterol (LDL-C) level by inhibiting 3-hydroxy-methylglutar...
Background/aims: To assess LDL-apheresis efficacy to lower Lp(a) and to compare the effects of Usual...
Contains fulltext : 23127___.PDF (publisher's version ) (Open Access
ObjectivesIn a randomized study we evaluated the effect of biweekly low density lipoprotein (LDL) ap...
Background/aims: To assess LDL-apheresis efficacy to lower Lp(a) and to compare the effects of Usual...
ObjectivesThis study sought to compare the effects of aggressive and conventional lipid lowering by ...
1 Statin therapy in patients with peripheral artery obstructive disease (PAOD) 1.1 Patients with lip...
Objective: Lowering low-density lipoprotein cholesterol (LDL-C) with statins has been demonstrated t...
1 Statin therapy in patients with peripheral artery obstructive disease (PAOD) 1.1 Patients with lip...
ObjectivesThis study sought to compare the effects of aggressive and conventional lipid lowering by ...
BackgroundThe 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are associated wi...
Increased blood cholesterol concentration is one of the main factors in ischemic heart disease, deve...
BACKGROUND: High LDL-cholesterol is a risk factor for atherosclerosis. We aimed to determine whether...
Item does not contain fulltextBACKGROUND: High LDL-cholesterol is a risk factor for atherosclerosis....
ObjectivesIn a randomized study we evaluated the effect of biweekly low density lipoprotein (LDL) ap...
Statins lower low density lipoprotein-cholesterol (LDL-C) level by inhibiting 3-hydroxy-methylglutar...
Background/aims: To assess LDL-apheresis efficacy to lower Lp(a) and to compare the effects of Usual...
Contains fulltext : 23127___.PDF (publisher's version ) (Open Access
ObjectivesIn a randomized study we evaluated the effect of biweekly low density lipoprotein (LDL) ap...
Background/aims: To assess LDL-apheresis efficacy to lower Lp(a) and to compare the effects of Usual...
ObjectivesThis study sought to compare the effects of aggressive and conventional lipid lowering by ...
1 Statin therapy in patients with peripheral artery obstructive disease (PAOD) 1.1 Patients with lip...
Objective: Lowering low-density lipoprotein cholesterol (LDL-C) with statins has been demonstrated t...
1 Statin therapy in patients with peripheral artery obstructive disease (PAOD) 1.1 Patients with lip...
ObjectivesThis study sought to compare the effects of aggressive and conventional lipid lowering by ...
BackgroundThe 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are associated wi...
Increased blood cholesterol concentration is one of the main factors in ischemic heart disease, deve...
BACKGROUND: High LDL-cholesterol is a risk factor for atherosclerosis. We aimed to determine whether...
Item does not contain fulltextBACKGROUND: High LDL-cholesterol is a risk factor for atherosclerosis....
ObjectivesIn a randomized study we evaluated the effect of biweekly low density lipoprotein (LDL) ap...
Statins lower low density lipoprotein-cholesterol (LDL-C) level by inhibiting 3-hydroxy-methylglutar...